• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Deep (Brain) Thoughts with Medtronic's Neuromodulation President

    Grab and Go: Examining the Thrombectomy Device Market

    Fine Print: A Discourse on Additive Manufacturing

    MPO's 2022 Medtech Industry Year in Review

    Micro Molding for Medtech Is Miniature Magic
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    BMP Medical Expands Sterling, Massachusetts Facility

    Abbott's Proclaim XR SCS OK'ed for Diabetic Neuropathy

    Environmental Sustainability Becoming Increasingly Important to Medtech Industry

    Duane DiFranco Joins Harvard MedTech’s Medical Advisory Board

    Lionel Bonte Named President of Mativ’s Healthcare and Wellness Business Unit
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Deep (Brain) Thoughts with Medtronic's Neuromodulation President

    Grab and Go: Examining the Thrombectomy Device Market

    Fine Print: A Discourse on Additive Manufacturing

    MPO's 2022 Medtech Industry Year in Review

    Micro Molding for Medtech Is Miniature Magic
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Reflections on 2022 and What’s Ahead for Medtech: MPO Sounding Board

    3 Ways to Prepare for ISO 13485/Part 820 Harmonization

    A New Home for Theranos' Elizabeth Holmes?

    Health Cost Drivers for Large Employers

    Braving Change: Facing Fears in the Midst of Major Transitions
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    JBC Technologies

    Medbio LLC

    Forefront Medical Technology

    NDH Medical Inc.

    Paragon Medical
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    How Artificial Intelligence Can Combat Key Issues Impacting Healthcare

    Why Advanced Sensors Are Crucial Within Medical Pumps

    How Artificial Intelligence Could Help Prevent 80% of Chronic Diseases

    4 Ways to Use Injection Molding in Medical Device Manufacturing

    Telemedicine and Connectivity to Drive Material Innovation in the Near Future
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    JBC Technologies

    Medbio LLC

    Forefront Medical Technology

    NDH Medical Inc.

    Paragon Medical
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    User Evaluation in the Absence of User Data with Platform Devices

    Accurate identification of the intended user population is not an option here.

    User Evaluation in the Absence of User Data with Platform Devices
    Finola Austin, Human Factors Engineering Manager, Owen Mumford05.03.21
    Human factors studies are essential to identify and eliminate any risks posed by drug delivery devices to the intended user. This, in turn, helps create user-centered designs that encourage patient adherence. Human factors guidance and international best practices, therefore, recommend that testing is performed on intended users, highlighting the importance of having test participants that reflect real end-users of the device and the therapy it contains. Targeted testing creates confidence in the results and their applicability to the wider user population.

    With platform devices that may be deployed across a range of therapeutic formulations, however, the intended therapy area and intended patient profile is not yet known. Accurate identification of the intended user population is not an option here. The device could be used by patients with different conditions and people who display different characteristics and levels of physical and cognitive abilities. Furthermore, manufacturers will need to consider that either a healthcare professional, caregiver, or a patient may use the device.

    Rather than simply testing the device on a specific target patient group, an inclusive strategy will be needed, wherein device safety and effectiveness are tested across a broad base of potential end-users. In order to meet the needs of all potential user groups, study samples will need to be carefully selected to ensure they are sufficiently representative of the potential patients. This will enable product designers to make informed decisions about the device, while also assuring business partners that any usability-related risk-factors have been uncovered and dealt with at the early stages of development.

    A good starting point for manufacturers will be to decide on an appropriate sample size to carry out the tests and demonstrate a thorough examination of the device and its use environment. Ensuring wide representation enables timely identification of use issues and relevant mitigations before development has gone too far. At the early stages of development, it is considered good practice to include five to eight participants per distinct user group in usability tests. The number of distinct user groups, however, may vary and is likely to be higher for platform devices given the unspecified intended user.

    Once five subjects have been tested, any major usability issues should have been detected, and the amount of additional information to be gained from adding more subjects starts to decrease. To demonstrate, one study showed that doubling the sample size from five to 10 subjects only increased the mean percentage of usability problems identified from 85.6 percent to 94.7 percent (Table 1). In the later stages of development, prospective customers will seek confirmation that their intended user has been thoroughly examined throughout the design process and any iterative user testing. U.S. and U.K. regulators recommend that 15 to 20 participants per user group are used for validation testing. This figure is deemed large enough to account for differences between users within the user population.


    Table 1: Percentage of total known usability problems found in 100 analysis samples (rounded to 1 decimal place)

    If each user group is composed of five to eight people in the early stages, the next step is to determine how many user groups are needed to cover the wide range of user characteristics and needs for platform devices. At Owen Mumford, we’ve developed a sound framework, which suggests dividing subjects into seven user groups (Table 2) to cover the range of characteristics that could influence the device’s usability for end-users.


    Table 2: Human Factors Sampling Strategy

    The sample plan includes four categories of people who may use the device or aid the patient in using the device, namely children and adults, caregivers, and healthcare professionals. The remaining three groups cover users’ capabilities in using and interacting with the device, known as perception, cognition, and action (PCA). For optimal results, it helps to make each use-impairment group mutually exclusive to demonstrate the impact of different aspects of the device interface on each user group. For prospective customers, this may be extremely helpful and a decisive factor in choosing a device.

    In order to make the sample group even more representative, the user groups above can be further broken down to include secondary characteristics such as gender, ethnicity, and hand dominance. One example of this could be to include people with biomechanical as well as neurological impairments within the seventh “Action” group (Table 2). Wherever errors or difficulties are encountered, this may help to identify the root cause.

    The challenge that comes with user evaluation plans is determining the right number of studies, the most appropriate stage of development to carry out studies, and the appropriate level of prototype fidelity. This is made more complicated in the case of platform devices given the lack of data on intended users. An effective sampling strategy is therefore critical to cover all bases and assess risk across the range of possible users. While a user evaluation sampling plan can be preceded by a less formal test with easy-to-access participants—such as members of the company—using a wide group of representative participants is recommended as early as possible.

    Using the human factors sampling strategy outlined in this article can serve as a valuable framework to anticipate the needs of future customers and meet best practices in the most cost-effective fashion.

    This sampling strategy may also be adjusted to the manufacturer’s specific needs. For instance, user groups may be larger to allow for greater diversity. Likewise, group sizes can be adjusted for commercial reasons, in order to align with the projected needs of the business or demonstrate a minimum representation of a specific comorbidity. 


    A highly experienced Human Factors Engineering Manager, Finola Austin boasts 15 years’ experience in mentorship and management of human factors services in safety-critical industries. Her career began in Occupational Therapy within acute, long term, and community settings, and her training in accessibility has given her special insight into the needs of impaired users. Since then, Finola has successfully planned and delivered Human Factors activities for hundreds of handheld medical devices, including auto injectors, emergency use devices, inhalers, injection pens, and lancets, and is proficient in the generation and review of documentation. She has executed numerous user evaluation studies in the United Kingdom and United States—including studies on safety engineered devices, injection pens, and color differentiation. 
    Related Searches
    • R&D & Design
    Related Knowledge Center
    • R&D & Design
      Loading, Please Wait..

      Trending
      • Study: Catheter Ablation Significantly Lowers Dementia Risk In AFib Patients
      • Tandem Diabetes Completes Deal For AMF Medical
      • BMP Medical Expands Sterling, Massachusetts Facility
      • The Future Of Biomedical Engineering Advancements
      • Abbott's Proclaim XR SCS OK'ed For Diabetic Neuropathy
      Breaking News
      • BMP Medical Expands Sterling, Massachusetts Facility
      • Abbott's Proclaim XR SCS OK'ed for Diabetic Neuropathy
      • Environmental Sustainability Becoming Increasingly Important to Medtech Industry
      • Duane DiFranco Joins Harvard MedTech’s Medical Advisory Board
      • Lionel Bonte Named President of Mativ’s Healthcare and Wellness Business Unit
      View Breaking News >
      CURRENT ISSUE

      November 2022

      • MPO's 2022 Year in Review
      • Fine Print: A Discourse on Additive Manufacturing
      • Grab and Go: Examining the Thrombectomy Device Market
      • View More >

      Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
      You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

      • About Us
      • Privacy Policy
      • Terms And Conditions
      • Contact Us

      follow us

      Subscribe
      Nutraceuticals World

      Latest Breaking News From Nutraceuticals World

      Vitamin D Supplementation Reduces Risk of Dynapenia
      Sustained-Release Caffeine Ingredient Offers Mood, Performance Benefits
      Multi-Strain Probiotic Improves Self-Reported Mood, Sleep, Serotonin Levels
      Coatings World

      Latest Breaking News From Coatings World

      Epoxytec Announces New Website Launch
      Paints and Coatings Market Worth $212B by 2026: MarketsandMarkets
      Axalta Releases Fourth Quarter and Full Year 2022 Results
      Medical Product Outsourcing

      Latest Breaking News From Medical Product Outsourcing

      BMP Medical Expands Sterling, Massachusetts Facility
      Abbott's Proclaim XR SCS OK'ed for Diabetic Neuropathy
      Environmental Sustainability Becoming Increasingly Important to Medtech Industry
      Contract Pharma

      Latest Breaking News From Contract Pharma

      Pasithea Signs CMC Development and Manufacturing Agreement
      Experic Expands Analytical Capabilities and Facilities
      List Labs Expands Manufacturing Capacity
      Beauty Packaging

      Latest Breaking News From Beauty Packaging

      Haircare Brand Uncle Funky’s Daughter Announces Retail Expansion
      TRESemmé Introduces New Pro Infusion Collection
      Walgreens Boots Alliance Shares 2022 ESG Report
      Happi

      Latest Breaking News From Happi

      KimChi Beauty Launches Spinning Hearts Love 02 Ahead of Valentine’s Day
      Dark & Lovely Names Actress Meagan Good Brand Ambassador
      Natural Household Care Company Tru Earth Adds Dishwasher Detergent Tablets
      Ink World

      Latest Breaking News From Ink World

      Xerox Releases 4Q, Full-Year 2022 Results
      Electronics For Imaging Names Frank Pennisi as CEO
      Fiery to Separate from EFI, Remain Wholly-Owned by Siris
      Label & Narrow Web

      Latest Breaking News From Label & Narrow Web

      EFI appoints Frank Pennisi CEO, Fiery now an independent business
      Bobst boosts senior sales team with Keith Nagle
      Penmar Industries adds Screen Truepress Jet L350UV SAI digital press
      Nonwovens Industry

      Latest Breaking News From Nonwovens Industry

      Essity’s Sales Grow
      Thinx to Pay up to $5 million to Settle Class Action Suit
      Typar Highlighting New Building Innovations
      Orthopedic Design & Technology

      Latest Breaking News From Orthopedic Design & Technology

      Orthofix Launches the Mariner Deformity System
      Tyber Medical Hires 2 New Execs
      Miach Ortho Raises $40M in Series B Funding
      Printed Electronics Now

      Latest Breaking News From Printed Electronics Now

      Smart Devices with Privacy Focus Have More Consumer Appeal
      Siman Group Partners with SML to Unlock Full Retail Potential with RFID
      Brewer Science Presents Optics Integration Solutions at SPIE Photonics West

      Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

      AD BLOCKER DETECTED

      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker.


      FREE SUBSCRIPTION Already a subscriber? Login